Archive for home use

Conflicts of interest? Abortion pill investor funds study claiming women want expanded distribution

Posted in Abortion pill, DANCO, David and Lucile Packard Foundation, George Soros, Journal Contraception, Population Council, RU-486, self-managed abortion, Warren Buffet with tags , , , , , , , , , , , , , , , , , , , , , on November 30, 2018 by saynsumthn

EXPOSED: Massive conflicts of interest found in new abortion pill study

abortion pill

Abortion industry insiders insist that there is a large public interest in expanding distribution of the abortion pill by lifting safety requirements for the drug regimen. Now, right on cue, a study done by abortion industry insiders and funded by a large investor of the abortion pill’s manufacturer purports to show that women want “alternative models” for obtaining the abortion pill. But the move is anything but organic and is being strategically driven by abortion industry insiders.

Published by the Journal Contraception, the study claims that women support obtaining abortion pills “(1) in advance from a doctor for future use, (2) over-the-counter (OTC) from a drugstore and (3) online without a prescription.” But there is more beneath the surface at play here. Not only are the Journal and its authors deeply embedded in the abortion industry, but the funding for this study also came from the David and Lucile Packard Foundation, a major investor in Danco, the manufacturer of the abortion pill.

In 1998, according to reports, Packard seeded Danco with $10 million, and Packard also currently funds Gynuity Health Projects, which conducts abortion pill clinical trials. Packard’s investment in Danco included a $14 million loan as early as 1996 to bring the drug to the US, as well as additional grants made in 2000, 2004, and 2009. And yet, the Journal claims there are no conflicts of interest.

Image: Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception)

Packard Foundation self managed abortion pill study (Image: 2018 study from Journal Contraception

Additional investors in Danco include George Soros (Open Society), Warren Buffet (Buffet Foundation) and the California-based Kaiser Family Foundation.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Journal Contraception  

Authors

Image: Journal Contraception 2018 study on self managed abortion

Journal Contraception 2018 study on self managed abortion

 

Image: Author Sarah Raifman Tweet June 2018 SB320 (Image: Twitter)

Author Sarah Raifman Tweet June 2018 SB320 (Image: Twitter)

  • Author Diana G. Foster is another ANSIRH staffer who opposes late-term abortion restrictions. She sits on the board of the Later Abortion Initiative (LAI), a group with the mission of “increas[ing] the number of sites where later abortion is available” and “expand[ing] the number of physicians who can perform later abortion, especially at 20 weeks’ gestation and beyond.” Foster has been applauded by the abortion advocacy group, NARAL.
Image: Author Diana G Foster applauded by NARAL 2016 tweet

Author Diana G Foster applauded by NARAL 2016 tweet

READ: Amazing: Over 500 babies saved thanks to abortion pill reversal

The abortion pill regimen, RU486, is made up of two drugs: Misoprostol and Mifeprex. This regimen is currently regulated by the FDA under a system known as REMS. As Live Action News previously explained, taking the abortion pill regimen isn’t just a simple thing — if a woman is too far along or if her pregnancy is ectopic, these factors put women at additional risk. There have been 22 reported deaths and thousands of hospitalizations since the abortion pill’s approval in 2000.

Live Action News has previously documented how:

  • Abortion insiders brought RU486 to the US.
  • Abortion insiders are conducting clinical trials for “home-use” and “self managed” abortions.
  • Abortion insiders collaborated to push “home use” abortions.
  • Abortion insiders recently coordinated a Tweetfest to promote “self-managed” abortions.
  • And now, abortion insiders conveniently roll out a study claiming women support “alternative models of medication abortion provision.”

Despite the clear conflicts of interest surrounding this study about the abortion pill, it and other studies like it are likely to go unchallenged by the mainstream media, just as abortion industry leader Planned Parenthood’s claims continue to go unchallenged. This does a grave disservice to women.

Abortion industry responsible for women dying from home use/ self managed abortions – here’s why!

Posted in Abortion death, Abortion pill, Abortionist, ACOG, Gynuity, Home Use Abortion, Planned Parenthood, Planned Parenthood Clinical Trials, RU-486, Self Managed Abortion with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , on September 27, 2018 by saynsumthn

The abortion industry is now pushing dangerous home abortions

By  |  Via LiveActionNews.org

abortion

When the abortion industry speaks about women dying from “home abortions”, they leave out the fact that historically, they were the ones lined up to assist women in obtaining illegal abortions. Today, the trend seems to be continuing. “Abortion AMA: Can I give myself an abortion?” published weeks ago by Bustle and written by Danielle Campoamor, points out that even though abortion is legal in the US, groups like Women Help Women are advising women on “self managed abortions.”

Image: Bustle promotes self abortions

Bustle promotes self abortions

A June 2018 BBC article reported, “By buying pills online and sharing medical advice through WhatsApp groups, women are increasingly turning to technology to sidestep legal barriers to abortion.” Women on Web, an international group that helps women obtain illegal abortions, suggests women lie about complications and tell the doctors they had a miscarriage instead. Despite warnings against purchasing drugs online, activists Francine Coeytaux and Victoria Nichols created the website, PlanC, to push dangerous home abortions.

Joanna Erdman, assistant professor at Dalhousie University’s Schulich School of Law in Halifax, told the New York Times that Plan C is the “same feminist ideology of ‘self-help’ that guided the many safe-abortion initiatives before it, including, most notably, the Abortion Counseling Service of Women’s Liberation, or Jane.”

Image: Plan C pushes home abortions

Plan C pushes home abortions

Today, despite Roe v. Wade remaining firmly in place, the industry is pushing a legal version of “home use” abortion.

The move, being tested in clinical trials, would allow the drug Mifeprex to be mailed to women, or obtained over-the-counter at a local pharmacy. Mifeprex is regulated by the FDA under Approved Risk Evaluation and Mitigation Strategies (REMS), which ensures that Mifeprex is only dispensed in certain healthcare settings by or under the supervision of a certified prescriber.

The abortion-inducing regimen is made up of two pills: Mifeprex, also known as mifepristone, and misoprostol, which, according to the FDA, will end “an early pregnancy (70 days or less since the first day of the last menstrual period).” Of course, “the pregnancy” is a term for ending the life of a preborn child in the womb. But sometimes these chemicals also claim the lives of their mothers. This process is explained by Dr. Anthony Levatino in the video below:

 

Between May 2009 and February 2011, Clinical Trials “to assess the acceptability of home-use mifepristone” were conducted and reviewed in the United States, Moldova, and the Republic of Nepal, sponsored by Gynuity Health Projects. The sponsor sought to recruit 615 women between 18 to 55 to enroll in the non-randomized study, Uptake and Acceptability of Home-use of Mifepristone for Medical Abortion. The trial within the USA included locations in three states — Georgia, New York and Pennsylvania:

Image: Feminist Women's Health Center home use abortion

Feminist Women’s Health Center home use abortion

Gynuity was founded in 2003 by Beverly Winikoff, M.D., M.P.H, and according to the website, “Winikoff was employed… at the Population Council.. Prior to joining the Council in 1978, she was Assistant Director for Health Sciences, The Rockefeller Foundation.”

Image: Gynuity Home Use Abortion

Senior Clinical Adviser Paul Blumenthal also currently serves as a member of the Board of Directors of the National Abortion Federation (NAF).

Gynuity is funded by organizations known for their support of abortion and population control, including:

  • The Bill and Melinda Gates Foundation
  • The David and Lucile Packard Foundation
  • The John D. and Catherine T. MacArthur Foundation
  • Planned Parenthood Global
  • Population Council
  • Society for Family Planning
  • The Rockefeller Foundation
  • The William and Flora Hewlett Foundation
Image: Abortion by Mail (Screen: The Atlantic)

Abortion by Mail (Screen: The Atlantic)

A report published by the pro-abortion journal ContraceptionAcceptability of Home-use of Mifepristone for Medical Abortion, reviewed a trial conducted from May 2009 through November 2010 at “four urban, demographically diverse clinical sites in New York City, Philadelphia and Atlanta…” which reported, “Four women in the home-use group and five women in the office-use group reported visiting the emergency room (ER) for care related to their abortion.”

Image: Home Use abortions send women to ER (Image: Journal Contraception)

Home Use abortions send women to ER (Image: Journal Contraception)

white paper overview written by authors at the Jacobs Institute of Women’s Health at George Washington University states, “More recent studies include one involving 400 women who received care at six US Planned Parenthood centers.” The Planned Parenthood home use study was conducted between April 2013 and June 2014, and results were published in Contraception, titled A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S, in 2015.

Abortion promoters are currently recruiting for a study at sites in California and Washington, where women will obtain the abortion pill regimen from the pharmacy instead of in the facility itself. Gynuity is also conducting clinical trials for the “Feasibility of Medical Abortion by Direct-to-Consumer Telemedicine,” or “mail order” abortion pills at select locations, including Planned Parenthood.

website, Teleabortion, has even been created to recruit for this experiment.

Image: Telabortion website

Telabortion website

While activists in favor of Roe and their complicit media allies claim abortion is safe, recent FDA reports indicate that almost a dozen women, who obtained pills at medical facilities, have died from it, and a thousand have been hospitalized.

Image: RU486 abortion pill deaths updated 2017

RU486 abortion pill deaths updated 2017

The real numbers may be difficult to track since, as Live Action News has previously documented, nearly half of all states do not require complications be reported. In addition, women suffering complications may present to the emergency room claiming they are suffering a miscarriage, without telling the truth about what has really happened.

In the years leading up to Roe v. Wade, advocates openly admitted that a majority of “illegal abortions” were being performed by “reputable physicians.” Past Planned Parenthood president Alan Guttmacher admitted to the Harvard Crimson in 1967 that “Seventy per cent of the illegal abortions in the country are performed by reputable physicians, each thinking himself a knight in white armor.”

Underground groups are already being formed to help commit “cheap, safe” abortions. There are also legal groups dedicated to “liberating” women who commit self-induced abortions. ACOG, which has shown itself to be pro-abortion, has also called for women to not be prosecuted for any self-induced abortions.

Regardless of the legal status of Roe v. Wade, women will continue to die, and the blame should be placed solely at the feet of the people who enable the killing to keep happening.

This article is reprinted with permission. The original appeared here at Live Action News.

Abortion strategy to fund abortion and bio-waste facilities, pass legislation

Posted in Abortion Strategy, ANSIRH, Guttmacher, Reproductive Health Investors Allianc, TARA Health Foundation with tags , , , , , , , , , , , , , , , , , , , , , , on September 6, 2018 by saynsumthn

EXPOSED: Abortion groups’ plan to ‘increase supply and demand’ for abortion

A 92-page report on the Tara Health Foundation website should be reviewed by pro-life advocates across the nation, as it details upcoming strategy from abortion supporters, which includes the push for “home use” abortions. Live Action News has previously covered how the philanthropic Foundation is behind funding RU-486 pills on college campuses in California and behind propping up the abortion chain Whole Woman’s Health while it battled safety regulations in Texas.

The “US Reproductive Health Investment Case” report from October of 2017 was put together by the “Reproductive Health Investors Alliance… to determine the most effective opportunities to improve access to reproductive health services… using both philanthropy and impact investments.” The report’s stated goal? “To increase the supply of and demand for… contraceptive and abortion services.”

Image: TARA Reproductive Health Investors Alliance Goal

TARA Reproductive Health Investors Alliance Goal

Image: Reproductive Health Investors Alliance Steering Committee

Reproductive Health Investors Alliance Steering Committee

The report includes statistics and analysis from “ANSIRH, the Guttmacher Institute, Ibis Reproductive Health, and the Kaiser Family Foundation.”

It should be noted that these agencies have abortion connections:

“Experts” who contributed to the report include:

The executive summary begins by pointing out the target:

… specific demographic groups (18-19 year olds, Black [WOC] and Hispanic women, and low-income women) that lag behind the national average in their rates of contraceptive use, the efficacy of contraceptives used and timing of abortion.

Live Action News has documented time and again that minority groups, which have a disproportionately high rate of abortion, are the target of the population control movement.

Image: TARA Reproductive Health Investors Alliance targeting women of color

TARA Reproductive Health Investors Alliance targeting women of color

The report identifies “40 example investment opportunities,” matched to “five challenge-specific investment strategies”:

a) research and development,
b) legislation & litigation,
c) pricing & reimbursement,
d) service provision, and
e) care-seeking by underserved populations

As Live Action News has documented, the report states that, “~50% of abortions are repeat abortions (460K abortions/year)” and it defines “woman” as those “in need of high quality contraceptive and abortion services” though the report “acknowledge[s] that this is a vast simplification.” The report also adds, “The term ‘woman’ does not describe the identity of all persons who can get pregnant; conversely, not all those who identify as a woman can get pregnant.”

Image: TARA Reproductive Health Investors Alliance legislative strategies

TARA Reproductive Health Investors Alliance legislative strategies

Pro-abortion legislative and litigation strategies suggested in the report include:

  • REMS removal strategy (This is the risk management system that governs the abortion pill RU486)
  • TRAP laws removal advocacy
  • Gestational bans removal advocacy
  • Criminality of self-induced abortion removal advocacy
  • Organizing led by women of color
  • Reproductive health or democracy reform PAC donations
  • Reproductive justice PAC donations

Image: Reproductive Health Investors Alliance abortion clinic strategy 1 of 2

Reproductive Health Investors Alliance strategy 1 of 2

Strategies that benefit abortion facilities include:

  • Investment in a biowaste facility that will collect from the facilities
  • Upstream investment to secure supply of firms able to build the facilities
  • Guarantees that enable the facilities to take out market rate loans
  • Readily available real estate or rental agreements for the facilities
  • Facilitate and train NPs, CNMs, PAs to commit abortions
  • Provide funding or loans for independent providers to join a telemedicine network
  • Innovations in telemedicine, mobile services, or at-home services that improve access
  • Provide free pregnancy diagnosis in abortion facilities to combat pregnancy resource centers

Image: Reproductive Health Investors Alliance abortion clinic strategy 2 of 2

Reproductive Health Investors Alliance strategy 2 of 2

Statistics from report unintentionally point to pro-life advances:

  • Since 2010, 338 state abortion restrictions have been adopted.
  • 90% of all U.S. counties lack an abortion provider.
  • 162 abortion providers closed down between 2011-2016. Only 21 abortion facilities opened during the same period.
  • An estimated 16 abortion facilities close each year due to financial challenges.
  • As of 2008, 97% of nonmetropolitan counties lacked an abortion provider.
  • There are an estimated 2,300 to 3,500 CPCs in the U.S. while there are only 1,800 abortion facilities.
  • Pregnancy resource centers outnumber these facilities 2:1.
  • Cost and difficulty getting malpractice insurance for independent providers is one of the biggest financial challenges for already resource strapped abortion facilities.
  • Viewing an ultrasound may contribute to a small proportion of women with medium or low decision certainty deciding to continue the pregnancy.
  • More than a third of Planned Parenthood’s budget comes from Medicaid, putting Planned Parenthood at risk if Medicaid funding is blocked.

The report proves the length abortion supporters intend to go to in order to guarantee the “right” to end the lives of tiny humans persons in the womb. And it clearly shows the impact that pro-life legislation, pro-life activism, and pro-life pregnancy centers are having on the abortion industry.

This article is reprinted with permission. The original appeared here at Live Action News.